183 related articles for article (PubMed ID: 38642250)
1. Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings.
Sobrino-García M; Muñoz-Bellido FJ; Moreno-Rodilla E; Martín-Muñoz R; García-Iglesias A; Dávila I
Int J Clin Pharm; 2024 Apr; ():. PubMed ID: 38642250
[TBL] [Abstract][Full Text] [Related]
2. β-Lactam allergy delabeling is safe and saves costs in Primary Care.
Quiralte J; Del Robledo Ávila M; Domínguez I; Menéndez E; Cisneros JM; Guisado AB
Aten Primaria; 2024 May; 56(11):102925. PubMed ID: 38795675
[TBL] [Abstract][Full Text] [Related]
3. Penicillin Allergy Delabeling Can Decrease Antibiotic Resistance, Reduce Costs, and Optimize Patient Outcomes.
Lee RU
Fed Pract; 2020 Oct; 37(10):460-465. PubMed ID: 33132684
[TBL] [Abstract][Full Text] [Related]
4. The impact of beta-lactam allergy labels on hospitalized children.
Jones TW; Fino N; Olson J; Hersh AL
Infect Control Hosp Epidemiol; 2021 Mar; 42(3):318-324. PubMed ID: 32938517
[TBL] [Abstract][Full Text] [Related]
5. Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations.
Anstey KM; Tsao L; Otani IM
Clin Rev Allergy Immunol; 2022 Jun; 62(3):484-504. PubMed ID: 35031956
[TBL] [Abstract][Full Text] [Related]
6. Penicillin skin testing in hospitalized patients with β-lactam allergies: Effect on antibiotic selection and cost.
King EA; Challa S; Curtin P; Bielory L
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):67-71. PubMed ID: 27211057
[TBL] [Abstract][Full Text] [Related]
7. The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study.
Chua KYL; Vogrin S; Bury S; Douglas A; Holmes NE; Tan N; Brusco NK; Hall R; Lambros B; Lean J; Stevenson W; Devchand M; Garrett K; Thursky K; Grayson ML; Slavin MA; Phillips EJ; Trubiano JA
Clin Infect Dis; 2021 Aug; 73(3):487-496. PubMed ID: 32756983
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Prospective Study of the Costs Associated With Evaluation of ß-Lactam Allergy.
Sobrino-García M; Muñoz-Bellido FJ; Moreno E; Macías E; Gracia-Bara MT; Laffond E; Lázaro-Sastre M; Martín-García C; de Arriba-Méndez S; Campanón-Toro MV; Gallardo-Higueras A; Dávila I
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):52-57. PubMed ID: 31599727
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study of Costs Associated with the Evaluation of β-Lactam Allergy in Children.
Sobrino M; Muñoz-Bellido FJ; Macías E; Lázaro-Sastre M; de Arriba-Méndez S; Dávila I
J Pediatr; 2020 Aug; 223():108-113.e2. PubMed ID: 32532647
[TBL] [Abstract][Full Text] [Related]
10. Promoting β-lactam utilization through suppression of electronic medical record cross-allergy alerts.
Boesch TS; Eischen E; Ries AM; Quinn A; Dave A; Beezhold DW
Am J Health Syst Pharm; 2022 May; 79(Suppl 2):S43-S52. PubMed ID: 35136927
[TBL] [Abstract][Full Text] [Related]
11. β-Lactam allergy testing and delabeling-Experiences and lessons from Singapore.
Heng YK; Liew YCC; Kong YL; Lim YL
Immun Inflamm Dis; 2020 Sep; 8(3):371-379. PubMed ID: 32506796
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Antibiotic Allergy Labels in a Large UK Hospital Population to Inform Antimicrobial Stewardship and Delabeling Assessment Strategy.
Jones NK; Morris B; Santos R; Nasser S; Gouliouris T
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2180-2189.e4. PubMed ID: 37088372
[TBL] [Abstract][Full Text] [Related]
13. [Translated article] The role of clinical pharmacists in patients with suspected allergy to β-lactams: A systematic review.
Cotrina Luque J; Rei MJ; Capoulas M; Santos C; Raimundo P
Farm Hosp; 2024; 48(1):T38-T44. PubMed ID: 37953114
[TBL] [Abstract][Full Text] [Related]
14. Delabeling, safety, and impact of β-lactam allergy testing: A systematic review.
Loprete J; Richardson R; Bramah V; Comben S; Li T; Beiglari L; O'Neill R; McEwan C; Carr A; Tong W;
J Allergy Clin Immunol Glob; 2023 Nov; 2(4):100160. PubMed ID: 37781667
[TBL] [Abstract][Full Text] [Related]
15. Implementation and outcomes of beta-lactam allergy management protocol at a comprehensive cancer center.
So W; Khalak SI; Ho S; Ross JA; Dadwal SS; Puing AG; Nanayakkara DD; Kaur A; Taplitz RA; Dickter JK
Infection; 2024 Jun; ():. PubMed ID: 38907094
[TBL] [Abstract][Full Text] [Related]
16. Development of a Pipeline for Removing Allergy Labels in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Merz LE; Huang GX; Mehta GD; Lynch DM; Maliborski N; Besz K; Wickner P; Cutler C; Castells M
Transplant Cell Ther; 2024 Mar; 30(3):322.e1-322.e10. PubMed ID: 38134971
[TBL] [Abstract][Full Text] [Related]
17. A novel 2-step process for the management of inpatient beta-lactam allergy labels.
Ravikumar R; Arora NS; Hanson R; Barhitte L; Nagel J; Aitken SL; Bashaw L; Gandhi T; Spranger E; Marshall VD; Eschenauer GA
Ann Allergy Asthma Immunol; 2024 Apr; 132(4):525-531.e1. PubMed ID: 38151095
[TBL] [Abstract][Full Text] [Related]
18. Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center.
Gorsline CA; Afghan AK; Stone CA; Phillips EJ; Satyanarayana G
Transpl Infect Dis; 2022 Oct; 24(5):e13885. PubMed ID: 35765165
[TBL] [Abstract][Full Text] [Related]
19. The role of clinical pharmacists in patients with suspected allergy to β-lactams: A systematic review.
Cotrina Luque J; Rei MJ; Capoulas M; Santos C; Raimundo P
Farm Hosp; 2024; 48(1):38-44. PubMed ID: 37696709
[TBL] [Abstract][Full Text] [Related]
20. A Multidisciplinary Quality Improvement Initiative to Facilitate Penicillin Allergy Delabeling Among Hospitalized Pediatric Patients.
Bauer ME; MacBrayne C; Stein A; Searns J; Hicks A; Sarin T; Lin T; Duffey H; Rannie M; Wickstrom K; Yang C; Bajaj L; Carel K
Hosp Pediatr; 2021 May; 11(5):427-434. PubMed ID: 33849960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
